CME; naltrexone, acamprosate, disufiram, SBIRT, abuse

Overview
Please note:This activity is no longer available for continuing education credit.
The burden of Alcohol Use Disorder (AUD) is often overshadowed by the widespread opioid epidemic; however, AUD is one of the most prevalent and life-altering substance abuse disorders worldwide. Our multidisciplinary experts dive into various approaches to the treatment of AUD. Join Drs. Edwin Salsitz, Ethan Cowan, and Annie Levesque as they view AUD through their respective psychiatric, emergency department, and family medicine lenses.
Disclosure of Conflicts of Interest
In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.
Host:
Edwin A. Salsitz, MD, DFASAM
Associate Clinical Professor
Mount Sinai Beth Israel
New York, NY
No relevant relationships reported
Faculty:
Ethan A. Cowan, MD
Professor of Emergency Medicine
Icahn School of Medicine at Mount Sinai
New York, NY
Consulting Fees: Indivior, LLC
Contracted Research: Gilead LLC
Royalties: Up-to-date
Annie Levesque, MD, MSc
Medical Director, Opioid Treatment Program, Mount Sinai West
Icahn School of Medicine at Mount Sinai
New York, NY
No relevant relationships reported
Reviewers/Content Planners/Authors:
- Cindy Davidson has nothing to disclose.
- Barry A. Fiedel, PhD, has nothing to disclose.
- Amanda Hilferty has nothing to disclose.
- John Maeglin has nothing to disclose.
- Colleen Resnick has nothing to disclose.
Learning Objectives
After participating in this educational activity, participants should be better able to:
- Recognize the rationale for screening patients for alcohol use disorder (AUD)
- Describe components of the screening, brief interview, and refer for treatment (SBIRT) process for moderate to severe AUD
- Describe how motivational interviewing can help patients accept their diagnosis and agree to treatment for moderate to severe AUD
- Formulate a treatment referral strategy designed to increase acceptance rates for patients with moderate to severe AUD
- Appraise the efficacy and safety of pharmacotherapy when treating moderate to severe AUD
- Compare the efficacy and safety of available off-label pharmacotherapies for moderate to severe AUD
- Discuss cases addressing the management of moderate to severe AUD
Target Audience
This activity is designed to meet the educational needs of emergency medicine physicians, primary care physicians, PAs, APNs, and nurses.
Accreditation and Credit Designation Statements
In support of improving patient care, Global Learning Collaborative (GLC) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Global Learning Collaborative (GLC) designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Global Learning Collaborative (GLC) designates this activity for 1 nursing contact hour. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
Global Learning Collaborative (GLC) has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.1 AAPA Category 1 CME credits. Approval is valid until March 31, 2024. PAs should claim only the credit commensurate with the extent of their participation in the activity.
Provider(s)/Educational Partner(s)
Prova Education designs and executes continuing education founded on evidence-based medicine, clinical need, gap analysis, learner feedback, and more. Our mission is to serve as an inventive and relevant resource for clinical content and educational interventions across a broad spectrum of specialties.
Prova Education's methodology demonstrates a commitment to continuing medical education and the innovative assessment of its effects. Our goal is clear—to develop and deliver the very best education in the most impactful manner and to verify its results with progressive outcomes research.
Commercial Support
This activity is supported by an independent educational grant from Alkermes, Inc.
Disclaimer
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Prova Education. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of Prova Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.
Reproduction Prohibited
Reproduction of this material is not permitted without written permission from the copyright owner.